Evans Kristin A, Halterman Jill S, Hopke Philip K, Fagnano Maria, Rich David Q
Department of Public Health Sciences, University of Rochester School of Medicine & Dentistry, 265 Crittenden Boulevard, CU 420644, Rochester, NY 14642, USA.
Department of Pediatrics, University of Rochester School of Medicine & Dentistry, 601 Elmwood Avenue, Box 777, Rochester, NY 14642, USA.
Environ Res. 2014 Feb;129:11-9. doi: 10.1016/j.envres.2013.12.001. Epub 2014 Jan 11.
Increased air pollutant concentrations have been linked to several asthma-related outcomes in children, including respiratory symptoms, medication use, and hospital visits. However, few studies have examined effects of ultrafine particles in a pediatric population. Our primary objective was to examine the effects of ambient concentrations of ultrafine particles on asthma exacerbation among urban children and determine whether consistent treatment with inhaled corticosteroids could attenuate these effects. We also explored the relationship between asthma exacerbation and ambient concentrations of accumulation mode particles, fine particles (≤2.5 micrograms [μm]; PM2.5), carbon monoxide, sulfur dioxide, and ozone. We hypothesized that increased 1-7 day concentrations of ultrafine particles and other pollutants would be associated with increases in the relative odds of an asthma exacerbation, but that this increase in risk would be attenuated among children receiving school-based corticosteroid therapy.
We conducted a pilot study using data from 3 to 10 year-old children participating in the School-Based Asthma Therapy trial. Using a time-stratified case-crossover design and conditional logistic regression, we estimated the relative odds of a pediatric asthma visit treated with prednisone (n=96 visits among 74 children) associated with increased pollutant concentrations in the previous 7 days. We re-ran these analyses separately for children receiving medications through the school-based intervention and children in a usual care control group.
Interquartile range increases in ultrafine particles and carbon monoxide concentrations in the previous 7 days were associated with increases in the relative odds of a pediatric asthma visit, with the largest increases observed for 4-day mean ultrafine particles (interquartile range=2088p/cm(3); OR=1.27; 95% CI=0.90-1.79) and 7-day mean carbon monoxide (interquartile range=0.17ppm; OR=1.63; 95% CI=1.03-2.59). Relative odds estimates were larger among children receiving school-based inhaled corticosteroid treatment. We observed no such associations with accumulation mode particles, black carbon, fine particles (≤2.5μm), or sulfur dioxide. Ozone concentrations were inversely associated with the relative odds of a pediatric asthma visit.
These findings suggest a response to markers of traffic pollution among urban asthmatic children. Effects were strongest among children receiving preventive medications through school, suggesting that this group of children was particularly sensitive to environmental triggers. Medication adherence alone may be insufficient to protect the most vulnerable from environmental asthma triggers. However, further research is necessary to confirm this finding.
空气污染物浓度升高与儿童多种哮喘相关结局有关,包括呼吸道症状、药物使用和住院就诊情况。然而,很少有研究探讨超细颗粒物在儿科人群中的影响。我们的主要目的是研究环境中超细颗粒物浓度对城市儿童哮喘加重的影响,并确定吸入性糖皮质激素持续治疗是否能减轻这些影响。我们还探讨了哮喘加重与积聚模态颗粒物、细颗粒物(≤2.5微克[μm];PM2.5)、一氧化碳、二氧化硫和臭氧的环境浓度之间的关系。我们假设超细颗粒物和其他污染物浓度在1 - 7天内升高与哮喘加重的相对几率增加有关,但接受学校糖皮质激素治疗的儿童中这种风险增加会减弱。
我们利用参与学校哮喘治疗试验的3至10岁儿童的数据进行了一项试点研究。采用时间分层病例交叉设计和条件逻辑回归,我们估计了在前7天污染物浓度升高与用泼尼松治疗的儿科哮喘就诊(74名儿童中的96次就诊)的相对几率。我们分别对通过学校干预接受药物治疗的儿童和常规护理对照组的儿童重新进行了这些分析。
前7天超细颗粒物和一氧化碳浓度的四分位间距增加与儿科哮喘就诊的相对几率增加有关,4天平均超细颗粒物(四分位间距 = 2088个/立方厘米;OR = 1.27;95% CI = 0.90 - 1.79)和7天平均一氧化碳(四分位间距 = 0.17 ppm;OR = 1.63;95% CI = 1.03 - 2.59)的增加最为明显。在接受学校吸入性糖皮质激素治疗的儿童中,相对几率估计值更大。我们未观察到与积聚模态颗粒物、黑碳、细颗粒物(≤2.5μm)或二氧化硫有此类关联。臭氧浓度与儿科哮喘就诊的相对几率呈负相关。
这些发现表明城市哮喘儿童对交通污染标志物有反应。在通过学校接受预防性药物治疗的儿童中影响最强,表明这组儿童对环境触发因素特别敏感。仅靠药物依从性可能不足以保护最脆弱的儿童免受环境性哮喘触发因素的影响。然而需要进一步研究来证实这一发现。